header_logo
cancel1

Brazil's CADE probes drugmaker for price hike

Credit: artisteer/iStock

Brazil’s public prosecutor has complained against Gilead Sciences to the country’s competition enforcer, CADE, reportedly about the drugmaker raising the price of a hepatitis C medication by more than 1400%.